▶ 調査レポート

ヒトワクチンアジュバントの中国市場2017

• 英文タイトル:China Human Vaccine Adjuvants Market Research Report 2017

QYResearchが調査・発行した産業分析レポートです。ヒトワクチンアジュバントの中国市場2017 / China Human Vaccine Adjuvants Market Research Report 2017 / A042109020資料のイメージです。• レポートコード:A042109020
• 出版社/出版日:QYResearch / 2017年3月21日
• レポート形態:英文、PDF、119ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥352,000 (USD3,200)▷ お問い合わせ
  Enterprise¥704,000 (USD6,400)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ヒトワクチンアジュバントの中国市場について調査・分析し、ヒトワクチンアジュバントの中国市場概観、ヒトワクチンアジュバントの種類別市場分析、用途別市場分析、ヒトワクチンアジュバントの中国市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、中国市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・ヒトワクチンアジュバントの中国市場概観
・ヒトワクチンアジュバントの種類別市場規模
・ヒトワクチンアジュバントの用途別市場規模
・ヒトワクチンアジュバントの中国市場規模
・ヒトワクチンアジュバントの中国市場予測
・ヒトワクチンアジュバントの製造メーカー分析
・ヒトワクチンアジュバントのメーカー別生産量
・ヒトワクチンアジュバントのメーカー別市場シェア
・ヒトワクチンアジュバントの価格動向・価格分析
・ヒトワクチンアジュバントの販売(売上高)動向
・ヒトワクチンアジュバントの貿易(輸出・輸入)動向
・ヒトワクチンアジュバントの産業チェーン分析
・ヒトワクチンアジュバントのマーケティング戦略分析
・ヒトワクチンアジュバントの販売業者(代理店)リスト
・ヒトワクチンアジュバントの市場環境分析
...

Notes:Sales, means the sales volume of Human Vaccine Adjuvants
Revenue, means the sales value of Human Vaccine Adjuvants

This report studies Human Vaccine Adjuvants in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
GSK
CSL Limited
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Oral
Subcutaneous
Intramuscular
Others
Split by Application, this report focuses on consumption, market share and growth rate of Human Vaccine Adjuvants in each application, can be divided into
Research Applications
Commercial Applications

レポート目次

Table of Contents

China Human Vaccine Adjuvants Market Research Report 2017
1 Human Vaccine Adjuvants Market Overview
1.1 Product Overview and Scope of Human Vaccine Adjuvants
1.2 Human Vaccine Adjuvants Segment by Type
1.2.1 China Production Market Share of Human Vaccine Adjuvants Type in 2015
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Applications of Human Vaccine Adjuvants
1.3.1 Human Vaccine Adjuvants Consumption Market Share by Application in 2015
1.3.2 Research Applications
1.3.3 Commercial Applications
1.4 China Market Size (Value) of Human Vaccine Adjuvants (2012-2022)
1.5 China Human Vaccine Adjuvants Status and Outlook
1.6 Government Policies

2 China Human Vaccine Adjuvants Market Competition by Manufacturers
2.1 China Human Vaccine Adjuvants Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Human Vaccine Adjuvants Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Human Vaccine Adjuvants Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Human Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Vaccine Adjuvants Market Competitive Situation and Trends
2.5.1 Human Vaccine Adjuvants Market Concentration Rate
2.5.2 Human Vaccine Adjuvants Market Share of Top 3 and Top 5 Manufacturers

3 China Human Vaccine Adjuvants Manufacturers Profiles/Analysis
3.1 GSK
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Human Vaccine Adjuvants Product Type, Application and Specification
3.1.2.1 Oral
3.1.2.2 Subcutaneous
3.1.3 GSK Human Vaccine Adjuvants Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 CSL Limited
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Human Vaccine Adjuvants Product Type, Application and Specification
3.2.2.1 Oral
3.2.2.2 Subcutaneous
3.2.3 CSL Limited 119 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Brenntag Biosector
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Human Vaccine Adjuvants Product Type, Application and Specification
3.3.2.1 Oral
3.3.2.2 Subcutaneous
3.3.3 Brenntag Biosector 130 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 SEPPIC
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Human Vaccine Adjuvants Product Type, Application and Specification
3.4.2.1 Oral
3.4.2.2 Subcutaneous
3.4.3 SEPPIC Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 SPI Pharma
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Human Vaccine Adjuvants Product Type, Application and Specification
3.5.2.1 Oral
3.5.2.2 Subcutaneous
3.5.3 SPI Pharma Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Novavax
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Human Vaccine Adjuvants Product Type, Application and Specification
3.6.2.1 Oral
3.6.2.2 Subcutaneous
3.6.3 Novavax Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Avanti Polar Lipids
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Human Vaccine Adjuvants Product Type, Application and Specification
3.7.2.1 Oral
3.7.2.2 Subcutaneous
3.7.3 Avanti Polar Lipids Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Aphios
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Human Vaccine Adjuvants Product Type, Application and Specification
3.8.2.1 Oral
3.8.2.2 Subcutaneous
3.8.3 Aphios Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview

4 China Human Vaccine Adjuvants Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Human Vaccine Adjuvants Capacity, Production and Growth (2012-2017)
4.2 China Human Vaccine Adjuvants Revenue and Growth (2012-2017)
4.3 China Human Vaccine Adjuvants Production, Consumption, Export and Import (2012-2017)

5 China Human Vaccine Adjuvants Production, Revenue (Value), Price Trend by Type
5.1 China Human Vaccine Adjuvants Production and Market Share by Type (2012-2017)
5.2 China Human Vaccine Adjuvants Revenue and Market Share by Type (2012-2017)
5.3 China Human Vaccine Adjuvants Price by Type (2012-2017)
5.4 China Human Vaccine Adjuvants Production Growth by Type (2012-2017)

6 China Human Vaccine Adjuvants Market Analysis by Application
6.1 China Human Vaccine Adjuvants Consumption and Market Share by Application (2012-2017)
6.2 China Human Vaccine Adjuvants Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaHuman Vaccine Adjuvants Market Analysis by Regions (Provinces)
7.1 China Human Vaccine Adjuvants Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Human Vaccine Adjuvants Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Human Vaccine Adjuvants Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Human Vaccine Adjuvants Sales Price by Regions (Provinces)(2012-2017)
7.2 China Human Vaccine Adjuvants Consumption by Regions (Provinces)(2012-2017)
7.3 China Human Vaccine Adjuvants Production, Consumption, Export and Import (2012-2017)

8 Human Vaccine Adjuvants Manufacturing Cost Analysis
8.1 Human Vaccine Adjuvants Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Human Vaccine Adjuvants

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Human Vaccine Adjuvants Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Human Vaccine Adjuvants Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Human Vaccine Adjuvants Market Forecast (2017-2022)
12.1 China Human Vaccine Adjuvants Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Human Vaccine Adjuvants Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Human Vaccine Adjuvants Production Forecast by Type (2017-2022)
12.4 China Human Vaccine Adjuvants Consumption Forecast by Application (2017-2022)
12.5 China Human Vaccine Adjuvants Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Human Vaccine Adjuvants Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Human Vaccine Adjuvants Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Human Vaccine Adjuvants Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Human Vaccine Adjuvants Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Human Vaccine Adjuvants
Figure China Production Market Share of Human Vaccine Adjuvants by Type in 2015
Figure Product Picture of Oral
Table Major Manufacturers of Oral
Figure Product Picture of Subcutaneous
Table Major Manufacturers of Subcutaneous
Figure Product Picture of Intramuscular
Table Major Manufacturers of Intramuscular
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Human Vaccine Adjuvants Consumption Market Share by Application in 2015
Figure Research Applications Examples
Figure Commercial Applications Examples
Figure China Human Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Table China Human Vaccine Adjuvants Capacity of Key Manufacturers (2015 and 2016)
Table China Human Vaccine Adjuvants Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Human Vaccine Adjuvants Capacity of Key Manufacturers in 2015
Figure China Human Vaccine Adjuvants Capacity of Key Manufacturers in 2016
Table China Human Vaccine Adjuvants Production of Key Manufacturers (2015 and 2016)
Table China Human Vaccine Adjuvants Production Share by Manufacturers (2015 and 2016)
Figure 2015 Human Vaccine Adjuvants Production Share by Manufacturers
Figure 2016 Human Vaccine Adjuvants Production Share by Manufacturers
Table China Human Vaccine Adjuvants Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Human Vaccine Adjuvants Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Human Vaccine Adjuvants Revenue Share by Manufacturers
Table 2016 China Human Vaccine Adjuvants Revenue Share by Manufacturers
Table China Market Human Vaccine Adjuvants Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Human Vaccine Adjuvants Average Price of Key Manufacturers in 2015
Table Manufacturers Human Vaccine Adjuvants Manufacturing Base Distribution and Sales Area
Table Manufacturers Human Vaccine Adjuvants Product Type
Figure Human Vaccine Adjuvants Market Share of Top 3 Manufacturers
Figure Human Vaccine Adjuvants Market Share of Top 5 Manufacturers
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Human Vaccine Adjuvants Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Human Vaccine Adjuvants Market Share (2012-2017)
Table CSL Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Limited Human Vaccine Adjuvants Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Limited Human Vaccine Adjuvants Market Share (2012-2017)
Table Brenntag Biosector Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Brenntag Biosector Human Vaccine Adjuvants Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Brenntag Biosector Human Vaccine Adjuvants Market Share (2012-2017)
Table SEPPIC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SEPPIC Human Vaccine Adjuvants Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure SEPPIC Human Vaccine Adjuvants Market Share (2012-2017)
Table SPI Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SPI Pharma Human Vaccine Adjuvants Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure SPI Pharma Human Vaccine Adjuvants Market Share (2012-2017)
Table Novavax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novavax Human Vaccine Adjuvants Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novavax Human Vaccine Adjuvants Market Share (2012-2017)
Table Avanti Polar Lipids Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Avanti Polar Lipids Human Vaccine Adjuvants Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Avanti Polar Lipids Human Vaccine Adjuvants Market Share (2012-2017)
Table Aphios Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aphios Human Vaccine Adjuvants Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Aphios Human Vaccine Adjuvants Market Share (2012-2017)
Figure China Human Vaccine Adjuvants Capacity, Production and Growth (2012-2017)
Figure China Human Vaccine Adjuvants Revenue (Million USD) and Growth (2012-2017)
Table China Human Vaccine Adjuvants Production, Consumption, Export and Import (2012-2017)
Table China Human Vaccine Adjuvants Production by Type (2012-2017)
Table China Human Vaccine Adjuvants Production Share by Type (2012-2017)
Figure Production Market Share of Human Vaccine Adjuvants by Type (2012-2017)
Figure 2015 Production Market Share of Human Vaccine Adjuvants by Type
Table China Human Vaccine Adjuvants Revenue by Type (2012-2017)
Table China Human Vaccine Adjuvants Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Human Vaccine Adjuvants by Type (2012-2017)
Figure 2015 Revenue Market Share of Human Vaccine Adjuvants by Type
Table China Human Vaccine Adjuvants Price by Type (2012-2017)
Figure China Human Vaccine Adjuvants Production Growth by Type (2012-2017)
Table China Human Vaccine Adjuvants Consumption by Application (2012-2017)
Table China Human Vaccine Adjuvants Consumption Market Share by Application (2012-2017)
Figure China Human Vaccine Adjuvants Consumption Market Share by Application in 2015
Table China Human Vaccine Adjuvants Consumption Growth Rate by Application (2012-2017)
Figure China Human Vaccine Adjuvants Consumption Growth Rate by Application (2012-2017)
Table China Human Vaccine Adjuvants Production by Regions (Provinces)(2012-2017)
Table China Human Vaccine Adjuvants Production Market Share by Regions (Provinces)(2012-2017)
Table China Human Vaccine Adjuvants Production Value by Regions (Provinces)(2012-2017)
Table China Human Vaccine Adjuvants Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Human Vaccine Adjuvants Sales Price by Regions (Provinces)(2012-2017)
Table China Human Vaccine Adjuvants Consumption by Regions (Provinces)(2012-2017)
Table China Human Vaccine Adjuvants Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Human Vaccine Adjuvants Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Vaccine Adjuvants
Figure Manufacturing Process Analysis of Human Vaccine Adjuvants
Figure Human Vaccine Adjuvants Industrial Chain Analysis
Table Raw Materials Sources of Human Vaccine Adjuvants Major Manufacturers in 2015
Table Major Buyers of Human Vaccine Adjuvants
Table Distributors/Traders List
Figure China Human Vaccine Adjuvants Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Human Vaccine Adjuvants Revenue and Growth Rate Forecast (2017-2022)
Table China Human Vaccine Adjuvants Production, Import, Export and Consumption Forecast (2017-2022)
Table China Human Vaccine Adjuvants Production Forecast by Type (2017-2022)
Table China Human Vaccine Adjuvants Consumption Forecast by Application (2017-2022)
Table China Human Vaccine Adjuvants Production Forecast by Regions (Provinces)(2017-2022)
Table China Human Vaccine Adjuvants Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Human Vaccine Adjuvants Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)